Incidental COVID-19 on PET/CT imaging
=====================================

* Reshma Amin
* Leonard Grinblat
* Mansoor Husain

A 58-year-old woman with diabetes and morbid obesity (body mass index 44.3 kg/m2) presented to an outpatient facility for routine staging for Hodgkins lymphoma using positron emission tomography–computed tomography (PET/CT) staging. The patient was prescreened outside the clinic doors, and she denied having any symptoms of coronavirus disease 2019 (COVID-19), was afebrile and had no history of travel or contact with anyone with COVID-19. She was injected with fluorodeoxyglucose F 18 (18F-FDG) radiotracer, after which she rested in the supine position in the injection room to allow radiotracer biodistribution, during which the patient was first overheard to have occasional coughing spells.

The PET/CT imaging confirmed the biopsy-proven, stage 2 right pelvic adenopathy (Figure 1A, white arrow), with only mild 18F-FDG activity (SUVmax 2.9). Imaging also showed that the patient had multifocal bilateral peripheral lung opacities (Figures 1C and 1D), with moderate 18F-FDG activity (SUVmax 4.5) in the left lower lobe (Figure 1C, white arrow). We did not find any pleural effusions or 18F-FDG-avid mediastinal adenopathy. One week before presentation, staging diagnostic CT of her chest was clear (Figure 1B).

![Figure 1:](http://www.cmaj.ca/https://www.cmaj.ca/content/cmaj/192/23/E631/F1.medium.gif)

[Figure 1:](http://www.cmaj.ca/content/192/23/E631/F1)

Figure 1: 
(A) Axial fused positron emission tomography–computed tomography (PET/CT) scan showing uptake of fluorodeoxyglucose F 18 (18F-FDG) of a lymphoma in the right pelvis (white arrow) of a 58-year-old woman. (B) Axial CT scan of the chest showing clear lung bases on examination performed 1 week before presentation to the clinic. (C) Axial fused PET/CT scan showing multifocal bilateral infiltrates with 18F-FDG activity most notably in the left lower lobe (white arrow) and (D) corresponding CT scan portion from the PET/CT showing multifocal bilateral infiltrates (black arrowheads).

We immediately notified the referring clinician, and the patient was sent for same-day testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with instructions to self-isolate. Two days later, a positive result for reverse transcriptase–polymerase chain reaction (RT–PCR) for SARS-CoV-2 was reported; concurrently, the patient had acquired a runny nose, more frequent coughing and fever (38°C).

Many outpatients have presented for diagnostic imaging after passing prescreening for COVID-19 and have unexpected findings on subsequent chest radiography and CT,1 typically multifocal ground-glass opacities or more dense infiltrates.2 On PET/CT, pneumonia associated with COVID-19 is 18F-FDG avid.3–5 Although some researchers have suggested that this modality may be a prognostic indicator, evidence is limited to case reports.3

Our patient was admitted to hospital for observation. Her symptoms abated over the course of a week, and she was discharged. Her planned course of pelvic radiation was delayed because of restrictions implemented during the COVID-19 pandemic.

## Acknowledgement

The authors thank Dr. Marc Freeman (MyHealth Centre, Toronto) for assistance with interpretation of positron emission tomography–computed tomography images.

## Footnotes

*   **Competing interests:** Leonard Grinblat and Mansoor Husain are minority shareholders in the privately owned facility (MyHealth Centre, Toronto) where this case originated. No other competing interests were declared.

*   This article has been peer reviewed.

*   The authors have obtained patient consent.

## References

1.  Pozzessere C, Rotzinger DC, Ghaye B, et al. Incidentally discovered COVID-19 pneumonia: the role of diagnostic imaging [letter]. Eur Radiol 2020 May 4 [Epub ahead of print]. doi:10.1007/s00330-020-06914-6.
    
    [CrossRef](http://www.cmaj.ca/lookup/external-ref?access_num=10.1007/s00330-020-06914-6&link_type=DOI) 

2.  Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020; 20:425–434.
    
    [PubMed](http://www.cmaj.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmaj%2F192%2F23%2FE631.atom) 

3.  Deng Y, Lei L, Chen Y, et al. The potential added value of FDG PET/CT for COVID-19 pneumonia. Eur J Nucl Med Mol Imaging 2020 Mar. 21 [Epub ahead of print]. doi:10.1007/s00259-020-04767-1.
    
    [CrossRef](http://www.cmaj.ca/lookup/external-ref?access_num=10.1007/s00259-020-04767-1&link_type=DOI) 

4.  Albano D, Bertagna F, Bertolia M, et al. Incidental findings suggestive of COVID-19 in asymptomatic patients undergoing nuclear medicine procedures in a high prevalence region. J Nucl Med 2020;61:632–6.
    
    [Abstract/FREE Full Text](http://www.cmaj.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Njoiam51bWVkIjtzOjU6InJlc2lkIjtzOjg6IjYxLzUvNjMyIjtzOjQ6ImF0b20iO3M6MjI6Ii9jbWFqLzE5Mi8yMy9FNjMxLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

5.  Lütje S, Marinova M, Kütting D, et al. Nuclear medicine in SARS-CoV-2 pandemia: 18F FDG-PET/CT to visualize COVID-19. Nuklearmedizi 2020 Apr. 7. [Epub ahead of print]. doi:10.1055/a-1152-2341.
    
    [CrossRef](http://www.cmaj.ca/lookup/external-ref?access_num=10.1055/a-1152-2341&link_type=DOI)